KR20210022240A - Whitening cosmetic compositions of oil in water emulsion with vitamin C derivative stable - Google Patents

Whitening cosmetic compositions of oil in water emulsion with vitamin C derivative stable Download PDF

Info

Publication number
KR20210022240A
KR20210022240A KR1020190101403A KR20190101403A KR20210022240A KR 20210022240 A KR20210022240 A KR 20210022240A KR 1020190101403 A KR1020190101403 A KR 1020190101403A KR 20190101403 A KR20190101403 A KR 20190101403A KR 20210022240 A KR20210022240 A KR 20210022240A
Authority
KR
South Korea
Prior art keywords
weight
oil
vitamin
cosmetic composition
derivative
Prior art date
Application number
KR1020190101403A
Other languages
Korean (ko)
Other versions
KR102309729B1 (en
Inventor
김선영
박현정
김기선
박명삼
Original Assignee
코스맥스 주식회사
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 코스맥스 주식회사 filed Critical 코스맥스 주식회사
Priority to KR1020190101403A priority Critical patent/KR102309729B1/en
Publication of KR20210022240A publication Critical patent/KR20210022240A/en
Application granted granted Critical
Publication of KR102309729B1 publication Critical patent/KR102309729B1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • A61K8/676Ascorbic acid, i.e. vitamin C
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04Dispersions; Emulsions
    • A61K8/06Emulsions
    • A61K8/062Oil-in-water emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41Amines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/02Preparations for care of the skin for chemically bleaching or whitening the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/48Thickener, Thickening system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59Mixtures
    • A61K2800/596Mixtures of surface active compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • Cosmetics (AREA)

Abstract

The present invention relates to an oil-in-water type cosmetic composition for skin whitening, containing a stable vitamin C derivative.

Description

비타민 C 유도체를 안정적으로 함유하는 수중유형 미백용 화장료 조성물 {Whitening cosmetic compositions of oil in water emulsion with vitamin C derivative stable}Whitening cosmetic compositions of oil in water emulsion with vitamin C derivative stable}

본 발명은 비타민 C 유도체를 안정적으로 함유하는 수중유형 미백용 화장료 조성물에 관한 것이다.The present invention relates to an oil-in-water type whitening cosmetic composition stably containing a vitamin C derivative.

미백과 주름개선의 기능성 화장품에 대한 실제 효과와 고효능 제품에 대한 니즈가 증가하면서 비타민 고함량 제품에 대한 개발이 증가하고 있다. The development of high-vitamin products is on the rise as the need for high-efficiency products and the actual effects of whitening and wrinkle improvement functional cosmetics are increasing.

비타민 C는 피부 내에서 타이로시나아제의 활성을 억제하는 기작으로 멜라닌 형성을 억제하며, 콜라겐 합성을 촉진하는 기능이 있어 피부의 미백과 노화 방지를 돕는다. Vitamin C is a mechanism that inhibits the activity of tyrosinase in the skin, inhibits melanin formation, and promotes collagen synthesis, helping to whiten the skin and prevent aging.

하지만, 원료 특성 상 빛과 열에 쉽게 산화되어 불안정화 된다. 물에 대한 용해도 (330 g/L)가 커서 쉽게 용해되나, 수용액 상태에서 산화 안정성이 저하되는 속도가 빠르기 때문에, 비타민 C를 고함량 배합할 시 에멀젼의 안정화가 쉽지 않다. However, due to the nature of the raw material, it is easily oxidized and destabilized by light and heat. The solubility in water (330 g/L) is large and it dissolves easily. However, since the rate at which the oxidation stability decreases in an aqueous solution is high, it is not easy to stabilize the emulsion when a high content of vitamin C is blended.

이러한 문제점을 개선하기 위하여 비타민 C의 산화 안정도를 개선한 다양한 비타민 C 유도체들이 개발되어왔다. 하지만, 비타민 C 유도체 또한 수중유형의 에멀젼에서 고함량 배합 시 경시 변화에 따른 산화에 의한 역가 하락과 변색 또는 제형의 점도 하락 등의 불안정화를 개선한 화장료의 개발이 미미한 실정이다.In order to improve this problem, various vitamin C derivatives with improved oxidation stability of vitamin C have been developed. However, the development of a cosmetic that improves destabilization such as a decrease in potency due to oxidation according to a change over time and instability such as discoloration or a decrease in the viscosity of a formulation when blended in a high content in an oil-in-water type emulsion is insignificant.

한국등록특허 제10-1817765호Korean Patent Registration No. 10-1817765 한국등록특허 제10-0252552호Korean Patent Registration No. 10-0252552 한국공개특허 제10-2007-0089327호Korean Patent Publication No. 10-2007-0089327

본 발명의 목적은 비타민 C 유도체를 안정적으로 함유하는 수중유형 미백용 화장료 조성물을 제공하는 것이다. It is an object of the present invention to provide an oil-in-water type whitening cosmetic composition stably containing a vitamin C derivative.

본 발명은 본 발명은 비타민 C 유도체를 안정적으로 함유하는 수중유형 미백용 화장료 조성물에 관한 것이다.The present invention relates to an oil-in-water type whitening cosmetic composition stably containing a vitamin C derivative.

이하 본 발명을 더욱 자세히 설명하고자 한다.Hereinafter, the present invention will be described in more detail.

본 발명의 일 예는 비타민 C 유도체를 안정적으로 함유하는 수중유형 미백용 화장료 조성물에 관한 것이다.An example of the present invention relates to an oil-in-water type whitening cosmetic composition stably containing a vitamin C derivative.

본 발명의 조성물은 조성물 총 중량 대비 비타민 C 유도체, pH 조절제 0.1 내지 5.0 중량%, 점증제 0.1 내지 5.0 중량%, 오일성분 1.0 내지 20.0 중량%, 계면활성제 0.1 내지 5.0 중량% 및 정제수를 포함하는 것일 수 있다.The composition of the present invention contains a vitamin C derivative, 0.1 to 5.0% by weight of a pH adjuster, 0.1 to 5.0% by weight of a thickener, 1.0 to 20.0% by weight of an oil component, 0.1 to 5.0% by weight of a surfactant, and purified water based on the total weight of the composition. I can.

본 발명에서 비타민 C 유도체를 포함하는 미백 화장료 조성물의 산화 안정성이 원료의 pH와 유사한 범위의 pH 조건(pH 4~6)에서 향상되어 만들어진 수중유형의 에멀젼의 점도 하락 및 변색이 발생하지 않음과 비타민 C 유도체의 역가가 유지되는 것을 확인하였다. 제조한 수중유형 에멀젼의 임상평가를 통하여 피험자의 피부 밝기와 투명도가 개선되는 것을 확인할 수 있었다. In the present invention, the oxidation stability of the whitening cosmetic composition containing the vitamin C derivative is improved in a pH condition (pH 4-6) in a range similar to that of the raw material, so that the viscosity decrease and discoloration of the oil-in-water emulsion do not occur. It was confirmed that the titer of the C derivative was maintained. Through clinical evaluation of the prepared oil-in-water emulsion, it was confirmed that the skin brightness and transparency of the subject were improved.

본 발명에 있어서 비타민 C 유도체는 조성물 총 중량 대비 1.0 내지 30.0 중량%, 2.0 내지 30.0 중량%, 3.0 내지 30.0 중량%, 4.0 내지 30.0 중량%, 1.0 내지 25.0 중량%, 2.0 내지 25.0 중량%, 3.0 내지 25.0 중량%, 4.0 내지 25.0 중량%, 1.0 내지 20.0 중량%, 2.0 내지 20.0 중량%, 3.0 내지 20.0 중량%, 4.0 내지 20.0 중량%, 1.0 내지 15.0 중량%, 2.0 내지 15.0 중량%, 3.0 내지 15.0 중량%, 4.0 내지 15.0 중량%, 1.0 내지 10.0 중량%, 2.0 내지 10.0 중량%, 3.0 내지 10.0 중량%, 4.0 내지 10.0 중량%, 예를 들어 5.0 중량% 포함된 것일 수 있다. 비타민 C 유도체의 함량이 1.0 중량% 미만일 경우 미백 효과를 기대하기 어려우며, 30.0 중량% 초과의 경우 피부 자극 우려가 있다.In the present invention, the vitamin C derivative is 1.0 to 30.0 wt%, 2.0 to 30.0 wt%, 3.0 to 30.0 wt%, 4.0 to 30.0 wt%, 1.0 to 25.0 wt%, 2.0 to 25.0 wt%, 3.0 to 25.0 wt%, 4.0 to 25.0 wt%, 1.0 to 20.0 wt%, 2.0 to 20.0 wt%, 3.0 to 20.0 wt%, 4.0 to 20.0 wt%, 1.0 to 15.0 wt%, 2.0 to 15.0 wt%, 3.0 to 15.0 wt% %, 4.0 to 15.0 wt%, 1.0 to 10.0 wt%, 2.0 to 10.0 wt%, 3.0 to 10.0 wt%, 4.0 to 10.0 wt%, for example 5.0 wt%. If the content of the vitamin C derivative is less than 1.0% by weight, it is difficult to expect a whitening effect, and if it is more than 30.0% by weight, there is a concern of skin irritation.

본 발명에 있어서 비타민 C 유도체는 에틸아스코르빌에테르(ethyl ascorbyl ether), 팔미틴산아스코빌(Ascorbyl Palmitate), 아스코빌테트라이소팔미테이트(Ascorbyl Tetra-Isopalmitate), 아스코빌글루코사이드(Ascorbyl Glucoside), 예를 들어, 에틸아스코르빌에테르인 것일 수 있으나, 이에 한정되는 것은 아니다. In the present invention, the vitamin C derivative is ethyl ascorbyl ether, ascorbyl palmitate, ascorbyl tetra-isopalmitate, ascorbyl glucoside, for example For example, it may be ethyl ascorbyl ether, but is not limited thereto.

본 발명에 있어서 pH 조절제는 화장료 조성물 총 중량 대비 0.1 내지 5.0 중량%, 0.1 내지 4.0 중량%, 0.1 내지 3.0 중량%, 0.1 내지 2.0 중량%, 0.1 내지 1.0 중량%, 0.1 내지 0.9 중량%, 0.1 내지 0.8 중량%, 0.1 내지 0.7 중량%, 0.1 내지 0.6 중량%, 0.1 내지 0.5 중량%, 0.1 내지 0.4 중량%, 0.1 내지 0.3 중량%, 0.1 내지 0.2 중량%, 예를 들어, 0.1 중량% 포함된 것일 수 있다. pH 조절제의 함량이 0.1 중량% 미만일 경우 점증제를 중화할 수 없어 점도가 높은 크림 제형을 기대하기 어려우며, 5.0 중량% 초과일 경우 pH가 높아져 비타민C 유도체의 안정도가 하락한다.In the present invention, the pH adjusting agent is 0.1 to 5.0% by weight, 0.1 to 4.0% by weight, 0.1 to 3.0% by weight, 0.1 to 2.0% by weight, 0.1 to 1.0% by weight, 0.1 to 0.9% by weight, 0.1 to 0.8% by weight, 0.1 to 0.7% by weight, 0.1 to 0.6% by weight, 0.1 to 0.5% by weight, 0.1 to 0.4% by weight, 0.1 to 0.3% by weight, 0.1 to 0.2% by weight, for example, 0.1% by weight I can. If the content of the pH adjuster is less than 0.1% by weight, it is difficult to expect a cream formulation with a high viscosity because the thickener cannot be neutralized. If it is more than 5.0% by weight, the pH increases and the stability of the vitamin C derivative decreases.

본 발명에 있어서 pH 조절제는 트리에탄올아민, 트로메타민, 소듐하이드록사이드, 포타슘하이드록사이드, 아미노메틸프로판올, 알지닌으로 이루어진 군으로부터 선택된 1종 이상인 것일 수 있으나, 이에 한정되는 것은 아니다. In the present invention, the pH adjusting agent may be one or more selected from the group consisting of triethanolamine, tromethamine, sodium hydroxide, potassium hydroxide, aminomethylpropanol, and arginine, but is not limited thereto.

본 발명에 있어서 점증제는 카보머인 것일 수 있으나, 이에 한정되는 것은 아니다. In the present invention, the thickener may be a carbomer, but is not limited thereto.

본 발명에 있어서 점증제는 화장료 조성물 총 중량 대비 0.1 내지 5.0 중량%, 0.1 내지 4.0 중량%, 0.1 내지 3.0 중량%, 0.1 내지 2.0 중량%, 0.1 내지 1.0 중량%, 0.2 내지 5.0 중량%, 0.2 내지 4.0 중량%, 0.2 내지 3.0 중량%, 0.2 내지 2.0 중량%, 0.2 내지 1.0 중량%, 0.3 내지 5.0 중량%, 0.3 내지 4.0 중량%, 0.3 내지 3.0 중량%, 0.3 내지 2.0 중량%, 0.3 내지 1.0 중량%, 0.4 내지 5.0 중량%, 0.4 내지 4.0 중량%, 0.4 내지 3.0 중량%, 0.4 내지 2.0 중량%, 0.4 내지 1.0 중량% 포함될 수 있으며, 예를 들어, 0.5 중량%인 것일 수 있다. 점증제가 0.1 중량% 미만일 경우 점증 효과를 기대하기 어려우며, 5.0 중량% 초과일 경우 특유의 끈적이는 사용감이 좋지 않다. In the present invention, the thickener is 0.1 to 5.0% by weight, 0.1 to 4.0% by weight, 0.1 to 3.0% by weight, 0.1 to 2.0% by weight, 0.1 to 1.0% by weight, 0.2 to 5.0% by weight, 0.2 to 4.0 wt%, 0.2 to 3.0 wt%, 0.2 to 2.0 wt%, 0.2 to 1.0 wt%, 0.3 to 5.0 wt%, 0.3 to 4.0 wt%, 0.3 to 3.0 wt%, 0.3 to 2.0 wt%, 0.3 to 1.0 wt% %, 0.4 to 5.0% by weight, 0.4 to 4.0% by weight, 0.4 to 3.0% by weight, 0.4 to 2.0% by weight, 0.4 to 1.0% by weight, for example, may be 0.5% by weight. If the thickener is less than 0.1% by weight, it is difficult to expect an increasing effect, and if it is more than 5.0% by weight, the characteristic sticky feeling is not good.

본 발명에 있어서 오일성분은 화장품에서 일반적으로 사용하는 오일성분 모두 적용 가능하며, 예를 들어, 피부 보습 효과에 도움을 주기 위하여 카프릴릭/카프릭트리글리세라이드(Caprylic/Capric Triglyceride), 세틸에틸헥사노에이트(Cetyl Ethylhexanoate), 세틸헥실팔미테이트(Ethylhexyl Palmitate), 네오펜틸글라이콜다이카프레이트(Neopentyl Glycol Dicaprate), 트라이에틸헥사노인(Triethylhexanoin), 하이드로제네이티드폴리데센(Hydrogenated Polydecene), 다이메티콘(Dimethicone), 사이클로펜타실록세인(Cyclopentasiloxane) 및 사이클로헥사실록세인(Cyclohexasiloxane)으로 구성된 군으로부터 선택된 1종 이상인 것일 수 있으나, 이에 한정되는 것은 아니다. In the present invention, the oil component can be applied to all oil components commonly used in cosmetics, for example, Caprylic/Capric Triglyceride, cetylethylhexa to help the skin moisturizing effect. Noate (Cetyl Ethylhexanoate), Cetylhexyl Palmitate (Ethylhexyl Palmitate), Neopentyl Glycol Dicaprate, Triethylhexanoin, Hydrogenated Polydecene, Dime It may be one or more selected from the group consisting of dimethicone, cyclopentasiloxane, and cyclohexasiloxane, but is not limited thereto.

본 발명에 있어서 오일성분은 화장료 조성물 총 중량 대비 1.0 내지 20.0 중량%, 1.0 내지 15.0 중량%, 1.0 내지 10.0 중량%, 1.0 내지 5.0 중량%, 2.0 내지 20.0 중량%, 2.0 내지 15.0 중량%, 2.0 내지 10.0 중량%, 2.0 내지 5.0 중량%, 예를 들어, 3.0 중량% 포함될 수 있다. 오일성분은 피부 위에 도포 시 얇은 오일막을 형성하며 이는 피부의 수분 증발 방지 역할을 하기 때문에 보습에 도움을 준다. 따라서, 오일성분이 1.0 중량% 미만으로 포함될 경우 화장품의 기본 효능인 보습 효과를 기대하기 어려우며, 20.0 중량% 초과 시 원료의 유분감으로 사용감이 나빠진다. In the present invention, the oil component is 1.0 to 20.0% by weight, 1.0 to 15.0% by weight, 1.0 to 10.0% by weight, 1.0 to 5.0% by weight, 2.0 to 20.0% by weight, 2.0 to 15.0% by weight, 2.0 to 10.0% by weight, 2.0 to 5.0% by weight, for example, may be included in 3.0% by weight. When applied on the skin, the oil component forms a thin film of oil, which helps moisturize because it prevents evaporation of moisture from the skin. Therefore, when the oil component is included in less than 1.0% by weight, it is difficult to expect a moisturizing effect, which is the basic effect of cosmetics, and when it exceeds 20.0% by weight, the feeling of use deteriorates due to the oiliness of the raw material.

본 발명에 있어서 계면활성제는 수중유형의 에멀젼 제조 시 사용하는 비이온성 계면활성제 모두 적용 가능하며, 예를 들어, 폴리솔베이트60 (Polysorbate 60), 폴리글리세릴-3메칠글루코오스디스테아레이트(Polyglyceryl-3 Methylglucose Distearate), 세테아릴글루코사이드(Cetearyl Glucoside), C12-20알킬글루코사이드(C12-20 Alkyl Glucoside), 세테아릴올리베이트 (Cetearyl Olivate), 솔비탄올리베이트(Sorbitan Olivate) 및 피이지-100스테아레이트(PEG-100 Stearate)로 이루어진 군으로부터 선택된 1종 이상인 것일 수 있으나, 이에 한정되는 것은 아니다.In the present invention, the surfactant can be applied to any of the nonionic surfactants used in the preparation of an oil-in-water emulsion. For example, polysorbate 60, polyglyceryl-3 methylglucose distearate (Polyglyceryl- 3 Methylglucose Distearate), Cetearyl Glucoside, C12-20 Alkyl Glucoside, Cetearyl Olivate, Sorbitan Olivate and PEG-100 Stea Rate (PEG-100 Stearate) may be one or more selected from the group consisting of, but is not limited thereto.

본 발명에 있어서 계면활성제는 화장료 조성물 총 중량 대비 0.1 내지 5.0 중량%, 0.1 내지 4.0 중량%, 0.1 내지 3.0 중량%, 0.1 내지 2.0 중량%, 0.5 내지 5.0 중량%, 0.5 내지 4.0 중량%, 0.5 내지 3.0 중량%, 0.5 내지 2.0 중량%, 1.0 내지 5.0 중량%, 1.0 내지 4.0 중량%, 1.0 내지 3.0 중량%, 1.0 내지 2.0 중량%, 예를 들어, 1.5 중량% 포함된 것일 수 있다. 계면활성제는 수중유형의 에멀젼에서 오일상의 계면을 단단하게 하여 장기 안정도에 도움을 준다. 계면활성제의 함량이 0.1 중랑% 미만인 경우 장기 안정도가 떨어질 수 있으며, 분자량이 작은 계면활성제를 사용할 경우 5.0 중량% 이상의 함량은 피부 자극에 대한 우려가 있다. In the present invention, the surfactant is 0.1 to 5.0% by weight, 0.1 to 4.0% by weight, 0.1 to 3.0% by weight, 0.1 to 2.0% by weight, 0.5 to 5.0% by weight, 0.5 to 4.0% by weight, 0.5 to 3.0% by weight, 0.5 to 2.0% by weight, 1.0 to 5.0% by weight, 1.0 to 4.0% by weight, 1.0 to 3.0% by weight, 1.0 to 2.0% by weight, for example, 1.5% by weight may be included. Surfactants help in long-term stability by hardening the oily interface in an oil-in-water emulsion. If the content of the surfactant is less than 0.1% by weight, long-term stability may be deteriorated, and if a surfactant having a small molecular weight is used, the content of 5.0% by weight or more may cause skin irritation.

본 발명은 비타민 C 유도체를 안정적으로 함유하는 수중유형 미백용 화장료 조성물에 관한 것으로, 주성분 산화에 의한 역가 하락이 발생하지 않아 비타민 C 유도체를 다량 함유하면서도 안정한 수중유형 미백 화장료를 제조할 수 있으며, 에멀젼 내 변색 방지제의 추가 없이도 고온(45℃) 및 상온 조건에서 변색이 발생하지 않고, 비타민 C 유도체 및 피부 pH와 유사한 약산성(pH 4 내지 5)의 수중유형 에멀젼을 제조할 수 있다.The present invention relates to an oil-in-water type whitening cosmetic composition stably containing a vitamin C derivative, and since there is no drop in titer due to oxidation of the main component, a stable oil-in-water type whitening cosmetic containing a large amount of vitamin C derivative can be prepared, Without the addition of an anti-discoloration agent, discoloration does not occur under high temperature (45° C.) and room temperature conditions, and a weakly acidic (pH 4 to 5) oil-in-water emulsion similar to a vitamin C derivative and skin pH can be prepared.

도 1a는 본 발명의 일 실시예에 따라 제조한 실시예 1의 안정도 확인(변색 여부) 결과를 보여주는 사진이다.
도 1b는 본 발명의 일 실시예에 따라 제조한 비교예 1의 안정도 확인(변색 여부) 결과를 보여주는 사진이다.
도 1c는 본 발명의 일 실시예에 따라 제조한 비교예 2의 안정도 확인(변색 여부) 결과를 보여주는 사진이다.
도 1d는 본 발명의 일 실시예에 따라 제조한 비교예 3의 안정도 확인(변색 여부) 결과를 보여주는 사진이다.
도 1e는 본 발명의 일 실시예에 따라 제조한 비교예 4의 안정도 확인(변색 여부) 결과를 보여주는 사진이다.
도 2는 본 발명의 일 실시예에 따라 피부 밝기 개선 효능을 평가한 결과를 보여주는 그래프이다.
도 3은 본 발명의 일 실시예에 따라 따라 피부 밝기 개선 효능을 평가한 결과를 보여주는 사진이다.
도 4a는 본 발명의 일 실시예에 따라 피부 투명도 개선 효능을 평가한 결과를 보여주는 그래프이다.
도 4b는 본 발명의 일 실시예에 따라 피부 투명도 개선 효능을 평가한 결과를 보여주는 그래프이다.
1A is a photograph showing a result of confirming the stability (whether discoloration) of Example 1 prepared according to an embodiment of the present invention.
1B is a photograph showing a result of confirming the stability (whether discoloration) of Comparative Example 1 prepared according to an embodiment of the present invention.
1C is a photograph showing a result of confirming the stability (whether discoloration) of Comparative Example 2 prepared according to an embodiment of the present invention.
1D is a photograph showing a result of confirming the stability (whether discoloration) of Comparative Example 3 prepared according to an embodiment of the present invention.
1E is a photograph showing a result of confirming the stability (whether discoloration) of Comparative Example 4 prepared according to an embodiment of the present invention.
2 is a graph showing a result of evaluating the effect of improving skin brightness according to an embodiment of the present invention.
3 is a photograph showing a result of evaluating the effect of improving skin brightness according to an embodiment of the present invention.
4A is a graph showing results of evaluating the effect of improving skin transparency according to an embodiment of the present invention.
4B is a graph showing results of evaluating the effect of improving skin transparency according to an embodiment of the present invention.

이하, 본 발명을 하기의 실시예에 의하여 더욱 상세히 설명한다. 그러나 이들 실시예는 본 발명을 예시하기 위한 것일 뿐이며, 본 발명의 범위가 이들 실시예에 의하여 한정되는 것은 아니다.Hereinafter, the present invention will be described in more detail by the following examples. However, these examples are for illustrative purposes only, and the scope of the present invention is not limited by these examples.

제조예. 실시예 1 및 비교예 1 내지 4Manufacturing example. Example 1 and Comparative Examples 1 to 4

실시예 1 및 비교예 1 내지 4는 하기 표 1에 기재된 각 성분과 함량에 따라 각 원료를 비이커에 계량한 후 75 내지 80℃의 온도에서 호모믹서(Homo mixer)를 이용하여 7000rpm으로 3분간 균일하게 혼합하였다. 혼합 후 같은 온도에서 증점제를 투입 후 7000rpm으로 3분간 균일하게 혼합하였다. 혼합 후 같은 온도에서 유상성분을 용해 후 7000rmp으로 5분간 균일하게 혼합하였다. 그 다음, 40 내지 45℃의 온도가 될 때까지 냉각하였고, 그 다음 주성분인 비타민 C 유도체를 용해 후 투입하여 7000rpm으로 5분간 균일하게 혼합하였다. 그 다음, 기포를 제거하고 냉각하여 각 화장료 조성물을 제조하였다. In Example 1 and Comparative Examples 1 to 4, each raw material was weighed in a beaker according to the components and contents shown in Table 1 below, and then uniformly at 7000 rpm for 3 minutes using a Homo mixer at a temperature of 75 to 80°C. Mixed well. After mixing, the thickener was added at the same temperature and uniformly mixed for 3 minutes at 7000 rpm. After mixing, the oily component was dissolved at the same temperature and uniformly mixed for 5 minutes at 7000rmp. Then, the mixture was cooled to a temperature of 40 to 45°C, and then the vitamin C derivative, which is a main component, was dissolved and added thereto, followed by uniformly mixing at 7000 rpm for 5 minutes. Then, air bubbles were removed and cooled to prepare each cosmetic composition.

하기 표 1에 비타민 C 유도체를 5.0% 함유하는 미백 화장료 조성물인 실시예 1 및 비교예 1 내지 4의 화장료 조성물의 성분과 함량을 나타내었다.In Table 1 below, the components and contents of the cosmetic compositions of Example 1 and Comparative Examples 1 to 4, which are whitening cosmetic compositions containing 5.0% of a vitamin C derivative, are shown.

성분 (중량%)Ingredient (% by weight) 용도Usage 실시예1Example 1 비교예1Comparative Example 1 비교예2Comparative Example 2
비교예 3

Comparative Example 3
비교예4Comparative Example 4
정제수Purified water 용제solvent 75.88 75.88 80.48 80.48 75.48 75.48 74.98 74.98 75.48 75.48 디소듐이디티에이Disodium EDTA 금속이온봉쇄제Metal ion sequestering agent 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 트로메타민Tromethamine pH 조절제pH adjuster 0.10 0.10 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 글리세린glycerin 보습제Moisturizer 10.00 10.00 10.00 10.00 10.00 10.00 10.00 10.00 10.00 10.00 에칠아스코빌에텔Echil Ascorville Etel 비타민 C 유도체Vitamin C derivatives 5.00 5.00 - - 5.00 5.00 5.00 5.00 5.00 5.00             카보머Carbomer 점증제Thickener 0.50 0.50 -- -- -- 0.50 0.50 아크릴레이트/C10-30알킬아크릴레이트크로스폴리머Acrylate/C10-30 alkyl acrylate crosspolymer 점증제Thickener -- 0.50.5 0.50.5 0.50.5 --             C14-22알코올/C12-20알킬글루코사이드C14-22 alcohol/C12-20 alkyl glucoside 계면활성제Surfactants 1.50 1.50 1.50 1.50 1.50 1.50 1.50 1.50 1.50 1.50 네오펜틸글라이콜디카프레이트Neopentyl glycol dicaprate 오일성분Oil component 3.00 3.00 3.00 3.00 3.00 3.00 3.00 3.00 3.00 3.00 옥틸도데칸올Octyldodecanol 오일성분Oil component 4.00 4.00 4.00 4.00 4.00 4.00 4.00 4.00 4.00 4.00 벤조트리아졸릴도데실p-크레졸Benzotriazolyldodecyl p-cresol 변색방지제Discoloration inhibitor - - - - - - 0.50 0.50 -- 합계Sum 100100 100100 100100 100100 100100

실험예 1. 경도 측정 및 변색 확인Experimental Example 1. Measurement of hardness and confirmation of discoloration

상기 제조된 화장료 조성물의 경도를 측정하여 하기 표 2에 기재하였다. 이때, 경도는 Rhetech사의 Fudoh Rheometer로 측정하였으며, 측정조건은 S.ADJ. 25, S.RANGE 1mm, RANGE 500, T.SPEED 2, STROKE 10mm 이다. 또한, pH meter는 Thermo scientific사의 ORION STAR A211로 측정하였으며, 측정조건은 정제수:에멀젼 = 15:1로 측정하였다. 변색 여부는 내용물을 투명한 크림 용기에 일정량 담아 제조 하루 후 색상 변화 여부를 확인하여, 그 결과를 표 2 및 도 1에 나타내었다. The hardness of the prepared cosmetic composition was measured and described in Table 2 below. At this time, the hardness was measured by Rhetech's Fudoh Rheometer, and the measurement conditions were S.ADJ. 25, S.RANGE 1mm, RANGE 500, T.SPEED 2, STROKE 10mm. In addition, the pH meter was measured with ORION STAR A211 of Thermo scientific, and the measurement conditions were measured as purified water: emulsion = 15:1. The color change was checked by putting the contents in a certain amount in a transparent cream container and checking whether the color changed after one day of manufacture, and the results are shown in Table 2 and FIG. 1.

실험 결과Experiment result 실시예1Example 1 비교예1Comparative Example 1 비교예2Comparative Example 2 비교예3Comparative Example 3 비교예4Comparative Example 4 경도값(Dyne/CM2)Hardness value (Dyne/CM 2 ) 3030 3030 1515 1515 2525 pH (1:15)pH (1:15) 4.54.5 6.56.5 5.85.8 5.85.8 5.85.8 변색 여부Whether it is discolored XX XX OO OO OO

표 2 및 도 1에서 확인할 수 있듯이, 실시예 1과 비교예 1을 제외하고 모두 노란색으로 변색되었다. 추가적으로 실시예 1을 상온(25℃)과 고온(45℃)에서 1달 간 보관 후 변색 여부를 확인하였을 때에도 내용물의 색상 변화는 없었다.As can be seen in Table 2 and FIG. 1, except for Example 1 and Comparative Example 1, all were discolored to yellow. Additionally, there was no change in color of the contents even when it was confirmed whether or not discoloration was observed after storing Example 1 at room temperature (25° C.) and high temperature (45° C.) for 1 month.

실험예 2. 비타민 C 유도체의 함량 분석 (역가 확인)Experimental Example 2. Analysis of the content of vitamin C derivatives (confirmation of potency)

상기 실시예 1에 의하여 제조된 에멀젼 내 비타민 C 유도체가 산화되지 않고 안정하게 유지되는지 함량 분석을 실시하였다. 상온(25℃)과 고온(45℃)에서 1달간 보관 후 LC로 분석하였다. 기기는 Agilent Technologies사의 1260 Infinity II을 사용하였으며 시험방법은 다음과 같다. Content analysis was performed to see if the vitamin C derivative in the emulsion prepared according to Example 1 was not oxidized and maintained stably. After storage for 1 month at room temperature (25°C) and high temperature (45°C), it was analyzed by LC. The instrument was Agilent Technologies' 1260 Infinity II, and the test method is as follows.

비타민 C 유도체 3 % 메탄올 용액을 표준액으로 하였고 RT와 45℃ 보관 시료를 각각 일정량 메탄올에 녹여 검액을 제조하였다. 검액 및 표준액을 액체크로마토그래프법에 따라 시험하여 피크 면적 대비 함량을 계산하여 하기 표 3에 나타내었다.A 3% methanol solution of the vitamin C derivative was used as a standard solution, and samples stored at RT and 45°C were dissolved in methanol in a certain amount to prepare a sample solution. The sample solution and the standard solution were tested according to the liquid chromatography method to calculate the content relative to the peak area, and are shown in Table 3 below.

보관조건Storage conditions RTRT 45℃45℃ 분석 결과Analysis 5.0±0.55.0±0.5 5.0±0.55.0±0.5

표 3에서 확인할 수 있듯이, 분석 결과 각 보관 조건에서 모두 비타민 C 유도체의 함량이 감소하지 않고 일정량 검출되어 안정하게 유지되는 것을 확인하였다.As can be seen in Table 3, as a result of the analysis, it was confirmed that the content of the vitamin C derivative did not decrease in all storage conditions, but was detected in a certain amount and maintained stable.

실험예 3. 미백 효능 평가 Experimental Example 3. Evaluation of whitening efficacy

하기 실시예 2로 제조한 화장료 조성물의 미백 효능을 하기와 같이 피부 밝기 개선과 피부 투명도 개선으로 평가하였으며, 성인 5명(평균나이 28.4세)의 결과를 평균을 산출하여 사용 전과 사용 후를 비교 평가하였다. 제품은 1일 2회, 2주간 사용하였다. 대조 제품으로는 비교예 5로 제조한 일반적인 미백 화장료 조성물을 사용하였다. The whitening effect of the cosmetic composition prepared in Example 2 below was evaluated by improving skin brightness and skin transparency as follows, and the results of 5 adults (average age 28.4 years old) were calculated as an average to compare before and after use. I did. The product was used twice a day for 2 weeks. As a control product, a general whitening cosmetic composition prepared in Comparative Example 5 was used.

성분 (중량%)Ingredient (% by weight) 용도Usage 실시예2Example 2 비교예5Comparative Example 5 정제수Purified water 용제solvent 78.93 78.93 78.9378.93 디소듐이디티에이Disodium EDTA 금속이온봉쇄제Metal ion sequestering agent 0.02 0.02 0.02 0.02 트로메타민Tromethamine pH 조절제pH adjuster 0.050.05 0.05 0.05 글리세린glycerin 보습제Moisturizer 10.00 10.00 10.00 10.00 에칠아스코빌에텔Echil Ascorville Etel 비타민 C 유도체Vitamin C derivatives 2.00 2.00 - - 나이아신아마이드Niacinamide 미백성분Whitening ingredients -- 2.002.00 카보머Carbomer 점증제Thickener 0.50 0.50 0.50.5       C14-22알코올/
C12-20알킬글루코사이드
C14-22 alcohol/
C12-20 alkyl glucoside
계면활성제Surfactants 1.50 1.50 1.50 1.50
네오펜틸글라이콜디카프레이트Neopentyl glycol dicaprate 오일성분Oil component 3.00 3.00 3.00 3.00 옥틸도데칸올Octyldodecanol 오일성분Oil component 4.00 4.00 4.00 4.00 벤조트리아졸릴도데실p-크레졸Benzotriazolyldodecyl p-cresol 변색방지제Discoloration inhibitor - - - - 합계Sum 100.00100.00 100.00100.00

3-1. 피부 밝기 개선 효능 평가3-1. Evaluation of the effect of improving skin brightness

시험 부위를 비누로 세안 후 10분간 항온항습실(22±2, 40 내지 60% PH)에서 대기한 후 시험 부위의 밝기를 0주와 2주후 Spectrophotometer(KONICA MINOLTA사)로 측정하였다. 3회 측정값의 평균을 산출하여 0주차 측정값과 비교 평가하여, 그 결과를 도 2 및 표 5에 나타내었다.After washing the test site with soap, wait in a constant temperature and humidity room (22±2, 40-60% PH) for 10 minutes, and then the brightness of the test site was measured with a spectrophotometer (KONICA MINOLTA) after 0 and 2 weeks. The average of the three measured values was calculated, compared with the measured value at week 0, and the results were shown in FIGS. 2 and 5.

L value 증감률(%, 0주차 대비)L value increase/decrease (%, compared to week 0) 실시예2Example 2 비교예5Comparative Example 5 결과값Result 3.03.0 1.51.5

도 2 및 표 5에서 확인할 수 있듯이, 실시예 2(시험 제품)와 비교예 5(대조로 제제품)로 제조한 화장료 조성물 사용 2주 후, L value 증감률은 각각 약 3.0 %, 1.5 %로 나타남에 따라 실시예 2로 제조한 시험제품이 밝기 개선 효과가 우수한 것으로 나타났다.As can be seen in Figure 2 and Table 5, after 2 weeks of use of the cosmetic composition prepared in Example 2 (test product) and Comparative Example 5 (manufactured by control), the L value increase and decrease rate were about 3.0% and 1.5%, respectively. As it appeared, it was found that the test product prepared in Example 2 had excellent brightness improvement effect.

3-2. 피부 투명도 개선 효능 평가3-2. Efficacy evaluation for improving skin transparency

시험 부위를 비누로 세안 후 10분간 항온항습실(22±2, 40 내지 60% PH)에서 대기한 후, 시험 부위의 피부투명도를 0주와 2주후 Antera 3D(MIRAVEX사)로 측정하였다. 3회 측정값의 평균을 산출하여 0주차 측정값과 비교 평가하여, 그 결과를 도 4a 및 표 6에 나타내었다. AREA 값이 증가할수록 피부 내부로 산란된 총 광량값이 증가한 것을 의미하며 이는 피부투명도가 개선됨을 의미한다. After washing the test site with soap, wait in a constant temperature and humidity room (22±2, 40-60% PH) for 10 minutes, and then the skin transparency of the test site was measured by Antera 3D (MIRAVEX) after 0 and 2 weeks. The average of the three measured values was calculated, compared with the measured value at week 0, and the results were shown in FIGS. 4A and 6. As the AREA value increases, it means that the total amount of light scattered into the skin increases, which means that the skin transparency is improved.

AREA (A.U)AREA (A.U) 실시예2Example 2 비교예5Comparative Example 5 0주0 weeks 2주2 weeks 0주0 weeks 2주2 weeks 결과값Result 4960349603 5044550445 4914749147 4818048180

또한, 도 4b 및 표 7에서 확인할 수 있듯이, 실시예 2로 제조한 시험제품은 2주 사용 후 AREA 값이 1.7로 증가하여 피부 투명도가 개선된 반면 대조제품은 AREA 값이 -2.0으로 피부 투명도 개선효과는 없는 것으로 확인되었다.In addition, as can be seen in Figure 4b and Table 7, the test product prepared in Example 2 increased the AREA value to 1.7 after 2 weeks of use, resulting in improved skin transparency, whereas the control product had an AREA value of -2.0, improving skin transparency. It was found to have no effect.

AREA 변화율 (%, 0주차 대비)Area change rate (%, compared to week 0) 실시예2Example 2 비교예5Comparative Example 5 결과값Result 1.71.7 -2.0-2.0

Claims (7)

비타민 C 유도체 1 내지 30 중량%, pH 조절제 0.1 내지 5.0 중량%, 점증제 0.1 내지 5.0 중량%, 오일성분 1.0 내지 20.0 중량 %, 계면활성제 0.1 내지 5.0 중량% 및 정제수를 포함하는 수중유형 미백용 화장료 조성물.An oil-in-water type whitening cosmetic comprising 1 to 30% by weight of a vitamin C derivative, 0.1 to 5.0% by weight of a pH adjuster, 0.1 to 5.0% by weight of a thickener, 1.0 to 20.0% by weight of an oil component, 0.1 to 5.0% by weight of a surfactant, and purified water Composition. 제1항에 있어서, 상기 비타민 C 유도체는 에틸아스코르빌에테르(ethyl ascorbyl ether)인 것인, 수중유형 미백용 화장료 조성물.The cosmetic composition of claim 1, wherein the vitamin C derivative is ethyl ascorbyl ether. 제1항에 있어서, 상기 pH 조절제는 트리에탄올아민, 트로메타민, 소듐하이드록사이드, 포타슘하이드록사이드, 아미노메틸프로판올, 알지닌으로 이루어진 군으로부터 선택된 1종 이상인 것인, 수중유형 미백용 화장료 조성물.The cosmetic composition of claim 1, wherein the pH adjusting agent is at least one selected from the group consisting of triethanolamine, tromethamine, sodium hydroxide, potassium hydroxide, aminomethylpropanol, and arginine. . 제1항에 있어서, 상기 점증제는 카보머인 것인, 수중유형 미백용 화장료 조성물.The cosmetic composition of claim 1, wherein the thickener is a carbomer. 제1항에 있어서, 상기 오일성분은 카프릴릭/카프릭트리글리세라이드(Caprylic/Capric Triglyceride), 세틸에틸헥사노에이트(Cetyl Ethylhexanoate), 세틸헥실팔미테이트(Ethylhexyl Palmitate), 네오펜틸글라이콜다이카프레이트(Neopentyl Glycol Dicaprate), 트라이에틸헥사노인(Triethylhexanoin), 하이드로제네이티드폴리데센(Hydrogenated Polydecene), 다이메티콘(Dimethicone), 사이클로펜타실록세인(Cyclopentasiloxane) 및 사이클로헥사실록세인(Cyclohexasiloxane)으로 구성된 군으로부터 선택된 1종 이상인 것인, 수중유형 미백용 화장료 조성물.The method of claim 1, wherein the oil component is caprylic/capric triglyceride, cetyl ethylhexanoate, cetylhexyl palmitate, neopentyl glycoldi Consisting of Caprate (Neopentyl Glycol Dicaprate), Triethylhexanoin, Hydrogenated Polydecene, Dimethicone, Cyclopentasiloxane, and Cyclohexasiloxane One or more selected from the group, the oil-in-water type whitening cosmetic composition. 제1항에 있어서, 상기 계면활성제는 비이온성 계면활성제인 것인, 수중유형 미백용 화장료 조성물.The cosmetic composition of claim 1, wherein the surfactant is a nonionic surfactant. 제6항에 있어서, 상기 비이온성 계면활성제는 폴리솔베이트60 (Polysorbate 60), 폴리글리세릴-3메칠글루코오스디스테아레이트(Polyglyceryl-3 Methylglucose Distearate), 세테아릴글루코사이드(Cetearyl Glucoside), C12-20알킬글루코사이드(C12-20 Alkyl Glucoside), 세테아릴올리베이트 (Cetearyl Olivate), 솔비탄올리베이트(Sorbitan Olivate) 및 피이지-100스테아레이트(PEG-100 Stearate)로 이루어진 군에서 선택된 1종 이상인 것인, 수중유형 미백용 화장료 조성물.The method of claim 6, wherein the nonionic surfactant is Polysorbate 60, Polyglyceryl-3 Methylglucose Distearate, Cetearyl Glucoside, C12- 20 Alkyl Glucoside (C12-20 Alkyl Glucoside), Cetearyl Olivate (Cetearyl Olivate), sorbitanolibate (Sorbitan Olivate) and PEG-100 Stearate (PEG-100 Stearate) at least one member selected from the group consisting of Phosphorus, an oil-in-water type cosmetic composition for whitening.
KR1020190101403A 2019-08-19 2019-08-19 Whitening cosmetic compositions of oil in water emulsion with vitamin C derivative stable KR102309729B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020190101403A KR102309729B1 (en) 2019-08-19 2019-08-19 Whitening cosmetic compositions of oil in water emulsion with vitamin C derivative stable

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020190101403A KR102309729B1 (en) 2019-08-19 2019-08-19 Whitening cosmetic compositions of oil in water emulsion with vitamin C derivative stable

Publications (2)

Publication Number Publication Date
KR20210022240A true KR20210022240A (en) 2021-03-03
KR102309729B1 KR102309729B1 (en) 2021-10-08

Family

ID=75151368

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020190101403A KR102309729B1 (en) 2019-08-19 2019-08-19 Whitening cosmetic compositions of oil in water emulsion with vitamin C derivative stable

Country Status (1)

Country Link
KR (1) KR102309729B1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102613551B1 (en) * 2023-03-23 2023-12-14 주식회사 베스트솔루션 High-content vitamin C powder, tablets and uses thereof

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102420773B1 (en) * 2021-10-22 2022-07-15 주식회사 코리아나화장품 Cream or paste type cosmetic composition comprising stabilized ascorbic acid
KR102452006B1 (en) 2022-06-15 2022-10-07 이훈 Whitening cosmetic composition containing mixed extracts of tangerine, rapeseed, bracken and camellia

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100252552B1 (en) 1995-05-09 2000-04-15 마이클 비. 설리반 Mixed oxide high index optical coating material and method
KR20070089327A (en) 2006-02-28 2007-08-31 (주)아모레퍼시픽 Composition for external application for skin whitening
KR20150049191A (en) * 2013-10-29 2015-05-08 주식회사 엘지생활건강 Skin whitening cosmetic compositions
KR20150121409A (en) * 2014-04-21 2015-10-29 (주)아모레퍼시픽 Method for stabilizing ascorbic acid 2-glucoside and a cosmetic composition containing the stabilized ascorbic acid 2-glucoside

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100252552B1 (en) 1995-05-09 2000-04-15 마이클 비. 설리반 Mixed oxide high index optical coating material and method
KR20070089327A (en) 2006-02-28 2007-08-31 (주)아모레퍼시픽 Composition for external application for skin whitening
KR20150049191A (en) * 2013-10-29 2015-05-08 주식회사 엘지생활건강 Skin whitening cosmetic compositions
KR101817765B1 (en) 2013-10-29 2018-02-21 주식회사 엘지생활건강 Skin whitening cosmetic compositions
KR20150121409A (en) * 2014-04-21 2015-10-29 (주)아모레퍼시픽 Method for stabilizing ascorbic acid 2-glucoside and a cosmetic composition containing the stabilized ascorbic acid 2-glucoside

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
[루이스토리] 멜라논크림 *
[시세이도] 화이트 인텐시브 스팟 타겟팅 세럼 *
[프로스틴] 비타민C 컨센트레이트 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102613551B1 (en) * 2023-03-23 2023-12-14 주식회사 베스트솔루션 High-content vitamin C powder, tablets and uses thereof

Also Published As

Publication number Publication date
KR102309729B1 (en) 2021-10-08

Similar Documents

Publication Publication Date Title
KR101591672B1 (en) Skin external preparation
US9248082B2 (en) Anti-aging composition containing phloretin
KR102309729B1 (en) Whitening cosmetic compositions of oil in water emulsion with vitamin C derivative stable
KR930007911B1 (en) External preparations free of discoloration
US11583488B2 (en) Method of improving penetration of a vitamin B3 compound into skin
EP3073987A1 (en) Polyol-in-oil-emulsions for dermal delivery
CA2681691A1 (en) Self tanning compositions containing dihydroxyacetone, a retinoid and ascorbic acid glucoside as a stabilizer
KR101539971B1 (en) Oil-in-water type emulsified sunscreen cosmetic
KR101406830B1 (en) Liquid skin-conditioning composition
US9655830B2 (en) Cosmetic composition
JP7307685B2 (en) Method for suppressing discoloration of topical composition containing adenosine phosphate and tranexamic acid
JP2010024204A (en) Skin care preparation
JP2023550111A (en) Stable skin care emulsion and its usage
JP7328957B2 (en) External composition containing ascorbic acid and/or its salt
KR20230077180A (en) Surfactant-free liquid cosmetic composition for uv blocking
KR20000038845A (en) Improved stability of water in oil type emulsion cosmetic composition comprising l-ascorbic acid and manufacturing method thereof
JPS62129212A (en) Cosmetic
KR20220114045A (en) Combination of vitamin A and vitamin C with improved stability
JPS6150908A (en) Skin cosmetic
KR20090085246A (en) A lip cosmetic composition
JP2012254957A (en) External skin preparation and production method thereof
US20030082220A1 (en) Cosmetics
JP2019131524A (en) Cosmetic and skin external preparation
JPH03279313A (en) External preparation of skin
JP2019043874A (en) Emulsion

Legal Events

Date Code Title Description
AMND Amendment
E601 Decision to refuse application
AMND Amendment
X701 Decision to grant (after re-examination)
GRNT Written decision to grant